Advertisement
Advertisement

MIRM

MIRM logo

Mirum Pharmaceuticals, Inc. Common Stock

96.72
USD
Sponsored
+0.41
+0.43%
Aug 24, 16:00 UTC -4
Closed
exchange

After-Market

96.76

+0.04
+0.04%

Mirum Pharmaceuticals, Inc. Common Stock Profile

About

Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's product candidate consists of maralixibat, an investigational oral drug in development for progressive familial intrahepatic cholestasis and Alagille syndrome. Mirum Pharmaceuticals Inc. is based in Foster City, United States.

Info & Links

CEO

Christopher Peetz

Headquarters

989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.mirumpharma.com

Auditor

Ernst & Young LLP

Share holders

91

Employees

372

Mirum Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

5.90B

Enterprise Value

6.32B

Enterprise Value/EBITDA(ttm)

-7.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

10.12

Price to Book(mrq)

--

Price to Cash(ytd)

1.89K

Profitability

Gross Margin(ttm)

81.65%

Operating Margin(ttm)

-12.31%

Profit Margin(ttm)

-133.50%

Return on Equity(ttm)

-36.28%

Return on Invested Capital(ttm)

-152.47%

Return on Assets(ttm)

-8.54%

Income Statement

Revenue(ttm)

618.07M

Revenue Per Share(ttm)

9.52

Gross Profit(ttm)

505.11M

EBITDA(ttm)3

-806.03M

Net Income Available to Common(ttm)

-860.21M

Diluted EPS(ttm)

-14.55

Share Statistics

Beta (5Y Monthly)

0.52

52-Week Change

35.23%

S&P 500 52-Week Change

18.66%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

64.93M

Dividend Yield

0.00%

Float4

59.53M

% Held by Insiders

8.32%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

438.29M

Total Cash Per Share(mrq)

6.75

Total Debt(mrq)

750.08M

Total Debt/Equity(mrq)

-7197.07%

Current Ratio(mrq)

2.86%

Quick Ratio(mrq)

2.74%

Book Value Per Share(mrq)

-0.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.31

Free Cash Flow(ytd)

-273.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement